Multiple Myeloma: Creating Personalized Treatment Options Through Clinical Trials
On Demand Replay Now Available.
- Select an “On Demand” session to watch right now.
- Select a “Replay” session to have a link sent to you.
In this joint program with The Leukemia & Lymphoma Society, join an expert-led discussion with Dr. Ajai Chari (UC San Francisco) and patient advocate Bryon Daily (The Leukemia & Lymphoma Society) as they discuss how clinical trials are changing the standard care options for relapsed and high-risk patients.
Key Topics:
Learn the differences between 3-drug vs. 4-drug regimens and when each is recommended
Compare the pros and cons of CAR T-cell therapy vs. bispecific antibodies
Hear real patient insights from Bryon Daily, myeloma patient advocate
Get expert tips on navigating disparities in access to treatment
Ask smarter questions at your next appointment by understanding your options
By registering, you agree to let us share your contact information with The Leukemia & Lymphoma Society.
We would like to thank The Leukemia & Lymphoma Society for their support.
Visit their Multiple Myeloma Overview for information and a list of resources to help you navigate myeloma.
The LLS also offers free resources like its Information Specialists, who are one free call away for support in different areas of blood cancer.
